Ashok Chaudhary, MD
Cardiovascular Disease · New Brunswick, NJNPI 1407022460
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $109,097 of the $144,366 with a category attached, or 75.6%. 17 manufacturers reported payments, led by Edwards Lifesciences at 58.3% of the total. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $376.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$84K
- Biosense Webster, Inc.$35K
- Medtronic$7K
- Medical Device Business Services, Inc.$7K
- Abbott$6K
- Boston Scientific$2K
- plus $4K from 11 others
What the payments were for
- Consulting fees$109,09776%
- Speaking & faculty fees$6,1004%
- Travel & lodging$18,48913%
- Food & beverage$10,6807%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 119 | $84,108 |
| Biosense Webster, Inc. | 45 | $35,201 |
| Medtronic(2 entities) | 44 | $7,066 |
| Medical Device Business Services, Inc. | 2 | $6,600 |
| Abbott | 72 | $5,921 |
| Boston Scientific | 40 | $1,954 |
| Abiomed | 40 | $1,769 |
| W. L. Gore & Associates, Inc. | 7 | $1,314 |
| Shockwave Medical, Inc | 1 | $91 |
| Biotronik Inc. | 1 | $85 |
| Johnson & Johnson | 3 | $69 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| ZOLL Circulation Inc | 2 | $50 |
| Angiodynamics, Inc. | 1 | $31 |
| Cardiva Medical, Inc. | 1 | $19 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$80,321
- Carto 3$41,285
- COREVALVE EVOLUT R$2,954
- CoreValve Evolut$2,895
- AMPLATZER AMULET$2,133
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,500
- GORE CARDIOFORM Septal Occluder$1,205
- Tendyne Mitral Valve System$1,081
- Impella$1,034
- TRICLIP$891
- WATCHMAN FLX$577
- AMPLATZER$261
- AVVIGO Guidance System$250
- Melody$244
- Mosaic$179
- WATCHMAN Access System$148
- AMPLATZER TALISMAN$135
- Mitra Clip system$126
- COMET$119
- Watchman$102
How this compares
$144,366 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 107 | $110,924 |
| EntrestoSacubitril/Valsartan | 24 | $29,338 |
| BrilintaTicagrelor | 47 | $29,046 |
| JardianceEmpagliflozin | 20 | $21,398 |
| Metoprolol Succinate | 135 | $2,387 |
| Atorvastatin Calcium | 117 | $1,316 |
| Rosuvastatin Calcium | 38 | $1,094 |
| ClopidogrelClopidogrel Bisulfate | 70 | $777 |
| Carvedilol | 48 | $516 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 25 | $331 |
| Losartan Potassium | 52 | $293 |
| Furosemide | 56 | $280 |
| Lisinopril | 25 | $277 |
| Amlodipine Besylate | 25 | $211 |
| Spironolactone | 15 | $156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $19 | $110,924107 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in New Brunswick
- Ramzan ZakirNew Brunswick$342K
- John KostisNew Brunswick$225K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
- Dilip ViswanathHaddon Heights$167K
- David PowellSpringfield$162K
- Fadi ChaabanWest Orange$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.